Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus …
J Stemler, N de Jonge, N Skoetz, J Sinkó… - The Lancet …, 2022 - thelancet.com
On the basis of improved overall survival, treatment guidelines strongly recommend
antifungal prophylaxis during remission induction chemotherapy for patients with acute …
antifungal prophylaxis during remission induction chemotherapy for patients with acute …
Approach to the older patient with acute myeloid leukemia
M Zimmer, T Kadia - Current oncology reports, 2023 - Springer
Abstract Purpose of Review This study aims to review the challenges of treating AML in
older patients, the spectrum of genomic aberrancies in this cohort, and discuss treatment …
older patients, the spectrum of genomic aberrancies in this cohort, and discuss treatment …
Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent
S On, CG Rath, M Lan, B Wu, KM Lau… - British Journal of …, 2022 - Wiley Online Library
We investigated the incidence of invasive fungal infections (IFIs) and other infectious
complications in patients receiving venetoclax and hypomethylating agent therapy for acute …
complications in patients receiving venetoclax and hypomethylating agent therapy for acute …
Incidence of invasive fungal infections in patients with previously untreated acute myeloid leukemia receiving venetoclax and azacitidine
Background Acute myeloid leukemia (AML) is associated with poor prognosis, particularly in
elderly patients with comorbidities. Combining azacitidine (AZA) with BCL-2 inhibitor …
elderly patients with comorbidities. Combining azacitidine (AZA) with BCL-2 inhibitor …
High-risk neutropenic fever and invasive fungal diseases in patients with hematological malignancies
G Mori, S Diotallevi, F Farina, R Lolatto, L Galli… - Microorganisms, 2024 - mdpi.com
Invasive fungal diseases (IFDs) still represent a relevant cause of mortality in patients
affected by hematological malignancies, especially acute myeloid leukaemia (AML) and …
affected by hematological malignancies, especially acute myeloid leukaemia (AML) and …
Fungal Intracranial Infections (Central Nervous System‐Invasive Fungal Disease) in Patients With Haematological Disorders—A Single‐Centre Retrospective Study
S Chattopadhyay, LJ Sumanth, HA Vanjare… - Mycoses, 2024 - Wiley Online Library
Background Invasive fungal disease (IFD) is a sinister complication encountered in patients
with haematological disorders. When occurring in the central nervous system (CNS), IFDs …
with haematological disorders. When occurring in the central nervous system (CNS), IFDs …
The Development of a Human-Relevant Pre-Clinical Mouse Model of Disseminated Cerebral Aspergillosis and Defining the Subsequent Neuroimmune Response
BN Sullivan - 2022 - search.proquest.com
Exposure of immunosuppressed individuals to the opportunistic fungal pathogen Aspergillus
(A.) fumigatus may result in invasive pulmonary aspergillosis (IPA), which could lead to the …
(A.) fumigatus may result in invasive pulmonary aspergillosis (IPA), which could lead to the …